<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Gene Editing in Medicine</title>
    <link rel="stylesheet" href="styles.css">
</head>
<body>
    <div class="header">
        <h1>Why Gene Editing Should Be Used In The Medical Field</h1>
    </div>
    <div class="page-container">
         <div class="sidebar">
             <h2>Remediation Project</h2>
             <p>By: Tyler McPhee</p>
             <p> </p>
             <p> </p>
             <h2>About The Author</h2>
             <p>In my senior year of high school, and I'm reading the book "Brave New World," which introduces me to a future where gene editing is commonplace. The idea of designing a fetus with "ideal" genes seems simultaneously fascinating and terrifying. Fast forward to today, and CRISPR is making headlines for its ability to tweak DNA sequences with incredible precision.</p>

        </div>
        <div class="posts">
            <div class="post">
                <h2>The Promise of Gene Editing in Medicine</h2>
                <p>CRISPR, a gene editing technology, has potential to revolutionize medicine by enabling precise genetic editing. In this vision, treatments could be customized to address genetic disorders at their root cause. This means diseases like cystic fibrosis and sickle cell anemia, which have been historically challenging to treat, could be effectively managed or even cured. The promise of CRISPR lies in its ability to bring hope to millions by offering the prospect of eradicating genetic diseases and significantly improving quality of life for those affected.</p>
                <ul>
                    <li>"CRISPR-Cas9 is a simple, inexpensive, and effective technique for gene editing with multiple applications from the development of functional genomics and epigenetics." - Choupina Ferreira</li>
                </ul>
            </div>

            <div class="post">
                <h2>Realizing the Potential: Transformative Treatments and Hope</h2>
                <p>One of the most heartwarming stories I've come across involves Johnny (who is in the third picture), a teenager battling sickle cell disease. Despite frequent pain crises, his life took a dramatic turn when he became one of the youngest recipients of a CRISPR-based treatment. His remarkable transformation, freed from the constant fear of pain, symbolizes hope not only for him but for countless others facing similar battles. It illustrates the power of scientific advancements to bring relief and new possibilities to those grappling with genetic disorders.</p>
                <ul>
                    <li>"Before the treatment, Johnny's life was constrained by the constant fear of pain crises. Yet, with the CRISPR treatment, Johnny has regained a sense of normalcy." - CNN</li>
                </ul>
            </div>

            <div class="post">
                <h2>Addressing Ethical Concerns</h2>
                <p>One pressing ethical dilemma is the potential for gene editing to exacerbate existing social inequalities. There's a legitimate fear that without careful regulation and oversight, genetic enhancements could be disproportionately available to the privileged few who can afford them, widening the gap between the haves and have-nots. This could lead to a future society where genetic advantages are concentrated among certain socio-economic classes, further entrenching disparities in health and opportunity.</p>
                <ul>
                    <li>"Without proactive measures to ensure equitable access to gene editing technologies, the promise of genetic advancements may remain out of reach for many." - Samuel Dickman</li>
                </ul>
            </div>

            <div class="post">
                <h2>Proposing Solutions</h2>
                <p>Navigating the complex ethical waters of gene editing requires an approach that addresses both regulatory oversight and equitable access. Enhanced regulation and oversight are necessary to ensuring that gene editing technologies are deployed responsibly and ethically. This means establishing strong frameworks that govern the research, development, and clinical application of gene editing therapies. These frameworks should prioritize safety, efficacy, and adherence to ethical principles such as respect for autonomy, beneficence, and justice.</p>
                <ul>
                    <li>"Proposing measures to ensure equitable access to gene editing technologies, particularly for underprivileged communities, is crucial." - Sneha Gulati</li>
                </ul>
            </div>

            <div class="post">
                <h2>Conclusion: Shaping the Future Responsibly</h2>
                <p>Embracing gene editing technology requires not only scientific prowess but also a deep sense of responsibility and compassion. We must proceed with caution, recognizing the weight of the decisions we make and the profound impact they can have on individuals, communities, and society as a whole. This means adhering to rigorous ethical standards, prioritizing safety and efficacy, and remaining vigilant against potential risks and unintended consequences.

At the same time, we must approach gene editing with a sense of compassion, recognizing its potential to alleviate suffering and improve lives. By harnessing this technology responsibly, we can offer hope to millions of people affected by genetic diseases, disabilities, and other health challenges. Gene editing holds the promise of personalized medicine tailored to individual genetic profiles, offering targeted treatments with unprecedented precision and effectiveness.</p>
            </div>
        </div>
        <div class="picture-section">
            <img src="https://images.ctfassets.net/cnu0m8re1exe/6ZItYuxFt0fXgWYpLwUir2/b2e01bf99af691a75282b153cfbf04db/shutterstock_1125283274__1_.jpg?fm=jpg&fl=progressive&w=660&h=433&fit=fill" alt="Description of the image">
            <img src="https://www.lubio.ch/assets/_processed_/6/b/csm_Blog-CRISPR-01_e9b4379675.jpg" alt="Description of the image">
            <img src="https://eurweb.com/wp-content/uploads/2024/01/Johnny-Lubin-Courtesy-JR-Lubin-and-Fabienne-Desir-cnn-L19jb21wb25lbnRzL2ltYWdlL2luc3RhbmNlcy9jbHB2cDM1dDYwMDA1M2I2aHNqdzYzeGJp-L19jb21.jpg" alt="Description of the image">
        </div>
        <div class="rightsidebar">
            <div class="works-cited">
                <h2>Works Cited</h2>
                <p>Dickman, Samuel. “Inequality and the Health-Care System in the USA - the Lancet.” Inequality and the Health-Care System in the USA, The Lancet, 8 Apr. 2017, www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)30398-7/fulltext.</p>
                <p>Ellacuria, Ekain. Ethical and Legal Aspects of Medical Gene Editing: Towards a New Eugenics, University of the Basque Country, 14 Feb. 2018, www.researchgate.net/profile/Ekain-Payan-Ellacuria.</p>
                <p>Ferreira, Patrick, and Altino Branco Choupina. “CRISPR/Cas9 a Simple, Inexpensive and Effective Technique for Gene Editing - Molecular Biology Reports.” SpringerLink, Springer Netherlands, 18 June 2022, link.springer.com/article/10.1007/s11033-022-07442-w#cities.</p>
                <p>Ghebreyesus, Tedros. “WHO Issues New Recommendations on Human Genome Editing for the Advancement of Public Health.” World Health Organization, World Health Organization, 12 July 2021, www.who.int/news/item/12-07-2021-who-issues-new-recommendations-on-human-genome-editing-for-the-advancement-of-public-health.</p>
                <p>Khan, Suliman, et al. “Role of Recombinant DNA Technology to Improve Life.” International Journal of Genomics, Hindawi, 8 Dec. 2016, www.hindawi.com/journals/ijg/2016/2405954/.</p>
                <p>Komaroff, Anthony. “Gene Editing Using CRISPR.” JAMA, JAMA Network, 22 Aug. 2017, jamanetwork.com/journals/jama/fullarticle/2646800.</p>
                <p>Mali, Prashant, et al. “Cas9 as a Versatile Tool for Engineering Biology.” Nature News, Nature Publishing Group, 27 Sept. 2013, www.nature.com/articles/nmeth.2649.</p>
                <p>Moez, Moez. “Overview of Traditional, Emerging, and Future Applications of Lab and Most Important Contributions of Genome Editing Tools for Food, Feed, and Pharmaceuticals.” Lactic Acid Bacteria as Cell Factories, Woodhead Publishing, 12 May 2023, www.sciencedirect.com/science/article/abs/pii/B9780323919302000079.</p>
                <p>Mulvihill, John J., et al. “Ethical Issues of CRISPR Technology and Gene Editing through the Lens of Solidarity.” OUP Academic, Oxford University Press, 23 Feb. 2017, academic.oup.com/bmb/article/122/1/17/3045812.</p>
                <p>Porteus, Matthew H, and Dana Carroll. “Gene Targeting Using Zinc Finger Nucleases.” Nature News, Nature Publishing Group, 8 Aug. 2005, www.nature.com/articles/nbt1125.</p>
                <p>Saurabh, Mahino, and Fatima Srivastav. “Impact of CRISPR-Based Gene Editing in Environmental Biotechnology: 1.” Taylor & Francis, Taylor & Francis, 4 July 2022, www.taylorfrancis.com/chapters/edit/10.1201/9781003186304-11/impact-crispr-based-gene-editing-environmental-biotechnology-saurabh-srivastav-mahino-fatima-mir-hilal-ahmad-amal-chandra-mondal?context=ubx.</p>
                <p>Tirrell, Meg. “FDA Approves Two Gene Therapies for Sickle Cell, Bringing Hope to Thousands with the Disease.” CNN, Cable News Network, 8 Dec. 2023, www.cnn.com/2023/12/08/health/first-crispr-gene-editing-treatment-sickle-cell-disease-scn/index.html.</p>
            </div>
        </div>
    </div>
</body>
</html>


